Learn more about zephyr valves here. Bronchoscopic lung volume reduction with zephyr valves improves lung function, exercise tolerance, and quality of life of patients with hyperinflated emphysema and little to no collateral ventilation The zephyr valve is a relatively new, noninvasive treatment that can help some people with severe copd. What is the success rate of the zephyr valve Clinical studies have shown that the zephyr valve can lead to significant improvements in lung function, exercise tolerance, and quality of life in appropriately selected patients. Results of the trial showed a 15 percent improvement in pulmonary capacity among 48 percent of those patients treated with the valve, compared with an improvement of 15 percent in only 17 percent of the control group.
However, the death rate in the zephyr valve group in the liberate study was 0.38 at 5 years, which compares favorably with the rate of 0.49 in the medical management group of a similar study. This multicenter, prospective, randomized controlled clinical trial of the zephyr endobronchial valve treatment in patients with heterogeneous emphysema distribution and little to no collateral ventilation demonstrates significant clinically meaningful benefits over current standard of care medical therapy in lung function, dyspnea, exercise capacity, and quality of life out to at least 12. For treating patients with severe emphysema Who is the zephyr® valve for The zephyr ® valve is for severe emphysema patients who consistently feel short of breath despite using copd medications and/or oxygen What are the benefits of zephyr® valves?
OPEN
